Novel ADAM-17 Inhibitor ZLDI-8 Enhances the in Vitro and in Vivo Chemotherapeutic Effects of Sorafenib on Hepatocellular Carcinoma Cells
Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-0804-6
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Springer Science and Business Media LLC